Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05132556 · ClinicalTrials.gov registry record · NA

The Influence of Beetroot Juice on Racial Disparities in Vascular Health

A NA study of Blood Pressure and Cardiovascular Risk Factor, sponsored by Georgia Southern University.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05132556: Completed NA study of Blood Pressure and Cardiovascular Risk Factor, sponsored by Georgia Southern University.

NCT05132556 is a NA study of Blood Pressure and Cardiovascular Risk Factor that has completed, run by Georgia Southern University. The registered enrollment target is 40 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05132556, a NA study of Blood Pressure and Cardiovascular Risk Factor, has completed, sponsored by Georgia Southern University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Black adults are 30% more likely to die from cardiovascular disease (CVD) compared to White adults, and more than half of this racial disparity in cardiovascular mortality may be attributed to the substantially greater prevalence of high blood pressure and vascular dysfunction in Black adults. Nitric oxide (NO) is a potent signaling molecule and key regular of vascular function that is suspected to be reduced in black individuals, but can be enriched by dietary nitrate (e.g., arugula, spinach, beets). The purpose of this study is to test the hypothesis that increasing NO bioavailability via nitrate-rich beetroot juice (BRJ) will lower blood pressure and improve vascular health in Black adults.

Primary Outcome

The investigators will use chemiluminescence detection to measure salivary and circulating NO metabolites (nitrate and nitrate).

Interventions

  • OTHER Acute Beetroot Juice

Study Locations (1)

Georgia

  • Biodynamics and Human Performance Center - Savannah

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-11-01
Est. Completion 2023-10-04
Phase NA
Georgia Southern University

4 total trials

What the finished NCT05132556 record still lists

NCT05132556 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (86% lower).

The record links to 3 conditions, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Acute Beetroot Juice is the first listed.

NCT05132556 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT05132556 about?

NCT05132556 is a clinical study titled "The Influence of Beetroot Juice on Racial Disparities in Vascular Health". Black adults are 30% more likely to die from cardiovascular disease (CVD) compared to White adults, and more than half of this racial disparity in cardiovascular mortality may be attributed to the substantially greater prevalence of high blood pressure and vascular dysfunction in Black adults. Nitri...

What is the current status of trial NCT05132556?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-11-01. Estimated completion is 2023-10-04.

What conditions does trial NCT05132556 study?

This clinical trial studies the following conditions: Blood Pressure, Cardiovascular Risk Factor, Racial Disparities.

What interventions are being tested in trial NCT05132556?

The interventions under investigation include: Acute Beetroot Juice (OTHER).

Who is sponsoring clinical trial NCT05132556?

This trial is sponsored by Georgia Southern University, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05132556 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05132556's enrollment target sits among peer trials

40 67th of 101 higher than 30 of 101 other Blood Pressure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05132556, the US trial registry maintained by the National Library of Medicine. NCT05132556 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.